Multiple interactions between transmembrane helices generate the oligomeric alpha1b-adrenoceptor

Juan J Carrillo1, Juan F López-Giménez, Graeme Milligan

  • 1Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, United Kingdom.

Molecular Pharmacology
|August 12, 2004
PubMed

Insights

This study reveals the complex quaternary structure of the alpha(1b)-adrenoceptor, highlighting key protein-protein interactions within its transmembrane domains. These findings suggest a symmetrical oligomeric structure, crucial for receptor function.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • The alpha(1b)-adrenoceptor's structure and function are not fully understood.
  • Elucidating the quaternary structure is essential for understanding receptor signaling and drug interactions.

Purpose of the Study:

  • To investigate the protein-protein interactions and quaternary structure of the alpha(1b)-adrenoceptor.
  • To identify specific transmembrane domains involved in receptor self-association and oligomerization.

Main Methods:

  • Coimmunoprecipitation assays.
  • Single-cell fluorescence resonance energy transfer (FRET).
  • Cell-surface time-resolved fluorescence resonance energy transfer (TR-FRET).

Main Results:

  • Demonstrated self-association of transmembrane domain 1 (TMD1) and its interaction with the full-length receptor, suggesting a symmetrical interface.
  • Identified interactions between the receptor and fragments of transmembrane domains 3/4 (TMD3/4) and 5/6 (TMD5/6), but not TMD7.
  • Observed symmetrical interactions involving TMD4 and contributions from TMD1/2, TMD3/4, and TMD5/6 to the quaternary structure.

Conclusions:

  • The alpha(1b)-adrenoceptor possesses a complex oligomeric quaternary structure.
  • Major symmetrical interactions likely define intradimeric contacts, with other contributions forming interdimer contacts.
  • The findings support a model of alpha(1b)-adrenoceptor oligomerization similar to murine rhodopsin.

Related Concept Videos

Multi-pass Transmembrane Proteins and β-barrels01:09

Multi-pass Transmembrane Proteins and β-barrels

In multi-pass transmembrane proteins, the polypeptide chain crosses the membrane more than once. The transmembrane polypeptide chain either forms an α-helix or β-strand structure. α-Helix containing multi-pass transmembrane proteins are ubiquitous, whereas β-strand containing ones are mainly found in gram-negative bacteria, mitochondria, and chloroplasts.
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as G-protein-linked receptors (GPCRs) and...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...